Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2024-10-10 00:00:00 ET · period of report 2024-10-08 · accession 0001415889-24-024986 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-10 | 2024-10-08 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $4.53 | -1,406 | 48.6K | -3% | -$6,369 |
| D | 2024-10-10 | 2024-10-08 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.55 | +1,960 | 50.0K | +4% | +$4,998 |
| D | 2024-10-10 | 2024-10-08 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.55 | -1,960 | 194.7K | -1.0% | -$4,998 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-10-08 | S | D | 1,406 | $4.53 | 48,623 | D | — | — | (F2) Shares sold to satisfy tax obligation on option exercise. |
| 2 | Common | Common Shares | 2024-10-08 | M | A | 1,960 | $2.55 | 50,029 | D | — | — | (F1) Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023. |
| 3 | Derivative | Common Shares | 2024-10-08 | M | D | 1,960 | $2.55 | 194,698 | D | $2.55 · 2014-11-07 to 2024-11-07 | 1,960 Options | (F3) Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023. |